- Home
- VFS vs BPMC Comparison
VFS vs BPMC Comparison
Compare VFS & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- BPMC
- Stock Information
- Founded
- VFS 2017
- BPMC 2008
- Country
- VFS Vietnam
- BPMC United States
- Employees
- VFS N/A
- BPMC N/A
- Industry
- VFS Blank Checks
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- VFS Finance
- BPMC Health Care
- Exchange
- VFS Nasdaq
- BPMC Nasdaq
- Market Cap
- VFS 8.2B
- BPMC 5.8B
- IPO Year
- VFS N/A
- BPMC 2015
- Fundamental
- Price
- VFS $3.25
- BPMC $101.35
- Analyst Decision
- VFS Buy
- BPMC Buy
- Analyst Count
- VFS 3
- BPMC 18
- Target Price
- VFS $5.75
- BPMC $125.88
- AVG Volume (30 Days)
- VFS 463.9K
- BPMC 789.4K
- Earning Date
- VFS 06-06-2025
- BPMC 05-01-2025
- Dividend Yield
- VFS N/A
- BPMC N/A
- EPS Growth
- VFS N/A
- BPMC N/A
- EPS
- VFS N/A
- BPMC N/A
- Revenue
- VFS $1,727,262,130.00
- BPMC $562,121,000.00
- Revenue This Year
- VFS N/A
- BPMC $44.49
- Revenue Next Year
- VFS $44.69
- BPMC $33.04
- P/E Ratio
- VFS N/A
- BPMC N/A
- Revenue Growth
- VFS 57.87
- BPMC 99.19
- 52 Week Low
- VFS $2.56
- BPMC $73.04
- 52 Week High
- VFS $5.38
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- VFS 37.65
- BPMC 56.34
- Support Level
- VFS $3.45
- BPMC $94.38
- Resistance Level
- VFS $3.79
- BPMC $102.52
- Average True Range (ATR)
- VFS 0.13
- BPMC 3.77
- MACD
- VFS -0.04
- BPMC -0.38
- Stochastic Oscillator
- VFS 0.00
- BPMC 79.29
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.